[go: up one dir, main page]

AU2874292A - Assay for malignant effusions - Google Patents

Assay for malignant effusions

Info

Publication number
AU2874292A
AU2874292A AU28742/92A AU2874292A AU2874292A AU 2874292 A AU2874292 A AU 2874292A AU 28742/92 A AU28742/92 A AU 28742/92A AU 2874292 A AU2874292 A AU 2874292A AU 2874292 A AU2874292 A AU 2874292A
Authority
AU
Australia
Prior art keywords
assay
malignant effusions
effusions
malignant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28742/92A
Inventor
Harold F Dvorak
Kiang-Teck Yeo
Tet-Kin Yeo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beth Israel Deaconess Medical Center Inc
Original Assignee
Beth Israel Deaconess Medical Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beth Israel Deaconess Medical Center Inc filed Critical Beth Israel Deaconess Medical Center Inc
Publication of AU2874292A publication Critical patent/AU2874292A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
AU28742/92A 1991-10-24 1992-10-21 Assay for malignant effusions Abandoned AU2874292A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US782350 1985-10-01
US78235091A 1991-10-24 1991-10-24

Publications (1)

Publication Number Publication Date
AU2874292A true AU2874292A (en) 1993-05-21

Family

ID=25125781

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28742/92A Abandoned AU2874292A (en) 1991-10-24 1992-10-21 Assay for malignant effusions

Country Status (4)

Country Link
AU (1) AU2874292A (en)
PT (1) PT101008A (en)
WO (1) WO1993008473A1 (en)
ZA (1) ZA928218B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006131A1 (en) * 1993-08-23 1995-03-02 Monash University A method for the assay, prophylaxis and/or treatment of human disease conditions

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6749853B1 (en) 1992-03-05 2004-06-15 Board Of Regents, The University Of Texas System Combined methods and compositions for coagulation and tumor treatment
US5660827A (en) * 1992-03-05 1997-08-26 Board Of Regents, The University Of Texas System Antibodies that bind to endoglin
US6093399A (en) * 1992-03-05 2000-07-25 Board Of Regents, The University Of Texas System Methods and compositions for the specific coagulation of vasculature
ES2193143T3 (en) * 1992-03-05 2003-11-01 Univ Texas USE OF IMMUNOCONJUGADOS FOR THE DIAGNOSIS AND / OR THERAPY OF VASCULARIZA TUMORS.
US6004555A (en) * 1992-03-05 1999-12-21 Board Of Regents, The University Of Texas System Methods for the specific coagulation of vasculature
US6036955A (en) * 1992-03-05 2000-03-14 The Scripps Research Institute Kits and methods for the specific coagulation of vasculature
US5877289A (en) * 1992-03-05 1999-03-02 The Scripps Research Institute Tissue factor compositions and ligands for the specific coagulation of vasculature
US5965132A (en) 1992-03-05 1999-10-12 Board Of Regents, The University Of Texas System Methods and compositions for targeting the vasculature of solid tumors
GB0207644D0 (en) * 2002-04-02 2002-05-15 Ark Therapeutics Ltd Peptides and their use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006131A1 (en) * 1993-08-23 1995-03-02 Monash University A method for the assay, prophylaxis and/or treatment of human disease conditions

Also Published As

Publication number Publication date
WO1993008473A1 (en) 1993-04-29
PT101008A (en) 1994-02-28
ZA928218B (en) 1993-04-30

Similar Documents

Publication Publication Date Title
AU5454094A (en) Multi-mode signal processing
AU633173B2 (en) Signal line
AU7971691A (en) Diaminopyrimidine compounds
AU4156293A (en) Thiazolylvinylphenyl derivatives
AU5007793A (en) Detail sander
AU4867990A (en) Bis-aza-bicyclic anxiolytic agents
AU3561193A (en) TNF-muteins
AU1062792A (en) Turntable
AU1443592A (en) Object carrier
AU3042892A (en) Rockbolt
AU7670391A (en) Magnesite-carbon refractories
AU685767B2 (en) Substituted benzazepinones
AU5668894A (en) Ghrh agonists
AU3406793A (en) 2-oxoquinoline derivatives
AU2874292A (en) Assay for malignant effusions
AU2831692A (en) Novel expression system
AU2415492A (en) Dual time-indicative time piece
AU2010992A (en) Novel azabicyclobenzisoquinolines
AU5727194A (en) Ghrh agonists
AU1183092A (en) Antalgic ointment
AU3461693A (en) Saddle-cloth
AU3562193A (en) Morpholin- and thiomorpholin-4-ylamides
AU3697893A (en) Propenoyl-imidazole derivatives
AU1732692A (en) Substituted imidazolinylpyrimidines
AU7790594A (en) Proximity detectors